Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
64
AOR Quote, Financials, Valuation and Earnings
Last price:
$65.37
Seasonality move
:
1.91%
Day range:
$65.24 - $65.51
52-week range:
$52.97 - $65.78
Dividend yield:
2.44%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
432.5K
Avg. volume:
358.1K
1-year change:
9.77%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AOR
iShares Core 60/40 Balanced Allocation ETF
|
-- | -- | -- | -- | -- |
|
AOA
iShares Core 80/20 Aggressive Allocation ETF
|
-- | -- | -- | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- |
|
URTH
iShares MSCI World ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AOR
iShares Core 60/40 Balanced Allocation ETF
|
$65.38 | -- | -- | -- | $0.27 | 2.44% | -- |
|
AOA
iShares Core 80/20 Aggressive Allocation ETF
|
$89.80 | -- | -- | -- | $0.25 | 2.04% | -- |
|
PPH
VanEck Pharmaceutical ETF
|
$100.54 | -- | -- | -- | $0.39 | 1.93% | -- |
|
URTH
iShares MSCI World ETF
|
$186.06 | -- | -- | -- | $1.26 | 1.27% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AOR
iShares Core 60/40 Balanced Allocation ETF
|
-- | 0.511 | -- | -- |
|
AOA
iShares Core 80/20 Aggressive Allocation ETF
|
-- | 0.652 | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | 0.233 | -- | -- |
|
URTH
iShares MSCI World ETF
|
-- | 1.135 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AOR
iShares Core 60/40 Balanced Allocation ETF
|
-- | -- | -- | -- | -- | -- |
|
AOA
iShares Core 80/20 Aggressive Allocation ETF
|
-- | -- | -- | -- | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- | -- |
|
URTH
iShares MSCI World ETF
|
-- | -- | -- | -- | -- | -- |
iShares Core 60/40 Balanced Allocation ETF vs. Competitors
-
Which has Higher Returns AOR or AOA?
iShares Core 80/20 Aggressive Allocation ETF has a net margin of -- compared to iShares Core 60/40 Balanced Allocation ETF's net margin of --. iShares Core 60/40 Balanced Allocation ETF's return on equity of -- beat iShares Core 80/20 Aggressive Allocation ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AORiShares Core 60/40 Balanced Allocation ETF-- -- -- AOAiShares Core 80/20 Aggressive Allocation ETF-- -- -- -
What do Analysts Say About AOR or AOA?
iShares Core 60/40 Balanced Allocation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Core 80/20 Aggressive Allocation ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Core 60/40 Balanced Allocation ETF has higher upside potential than iShares Core 80/20 Aggressive Allocation ETF, analysts believe iShares Core 60/40 Balanced Allocation ETF is more attractive than iShares Core 80/20 Aggressive Allocation ETF.
Company Buy Ratings Hold Ratings Sell Ratings AORiShares Core 60/40 Balanced Allocation ETF0 0 0 AOAiShares Core 80/20 Aggressive Allocation ETF0 0 0 -
Is AOR or AOA More Risky?
iShares Core 60/40 Balanced Allocation ETF has a beta of 0.646, which suggesting that the stock is 35.369% less volatile than S&P 500. In comparison iShares Core 80/20 Aggressive Allocation ETF has a beta of 0.777, suggesting its less volatile than the S&P 500 by 22.306%.
-
Which is a Better Dividend Stock AOR or AOA?
iShares Core 60/40 Balanced Allocation ETF has a quarterly dividend of $0.27 per share corresponding to a yield of 2.44%. iShares Core 80/20 Aggressive Allocation ETF offers a yield of 2.04% to investors and pays a quarterly dividend of $0.25 per share. iShares Core 60/40 Balanced Allocation ETF pays -- of its earnings as a dividend. iShares Core 80/20 Aggressive Allocation ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AOR or AOA?
iShares Core 60/40 Balanced Allocation ETF quarterly revenues are --, which are smaller than iShares Core 80/20 Aggressive Allocation ETF quarterly revenues of --. iShares Core 60/40 Balanced Allocation ETF's net income of -- is lower than iShares Core 80/20 Aggressive Allocation ETF's net income of --. Notably, iShares Core 60/40 Balanced Allocation ETF's price-to-earnings ratio is -- while iShares Core 80/20 Aggressive Allocation ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Core 60/40 Balanced Allocation ETF is -- versus -- for iShares Core 80/20 Aggressive Allocation ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AORiShares Core 60/40 Balanced Allocation ETF-- -- -- -- AOAiShares Core 80/20 Aggressive Allocation ETF-- -- -- --
-
Which has Higher Returns AOR or PPH?
VanEck Pharmaceutical ETF has a net margin of -- compared to iShares Core 60/40 Balanced Allocation ETF's net margin of --. iShares Core 60/40 Balanced Allocation ETF's return on equity of -- beat VanEck Pharmaceutical ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AORiShares Core 60/40 Balanced Allocation ETF-- -- -- PPHVanEck Pharmaceutical ETF-- -- -- -
What do Analysts Say About AOR or PPH?
iShares Core 60/40 Balanced Allocation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Pharmaceutical ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Core 60/40 Balanced Allocation ETF has higher upside potential than VanEck Pharmaceutical ETF, analysts believe iShares Core 60/40 Balanced Allocation ETF is more attractive than VanEck Pharmaceutical ETF.
Company Buy Ratings Hold Ratings Sell Ratings AORiShares Core 60/40 Balanced Allocation ETF0 0 0 PPHVanEck Pharmaceutical ETF0 0 0 -
Is AOR or PPH More Risky?
iShares Core 60/40 Balanced Allocation ETF has a beta of 0.646, which suggesting that the stock is 35.369% less volatile than S&P 500. In comparison VanEck Pharmaceutical ETF has a beta of 0.549, suggesting its less volatile than the S&P 500 by 45.102%.
-
Which is a Better Dividend Stock AOR or PPH?
iShares Core 60/40 Balanced Allocation ETF has a quarterly dividend of $0.27 per share corresponding to a yield of 2.44%. VanEck Pharmaceutical ETF offers a yield of 1.93% to investors and pays a quarterly dividend of $0.39 per share. iShares Core 60/40 Balanced Allocation ETF pays -- of its earnings as a dividend. VanEck Pharmaceutical ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AOR or PPH?
iShares Core 60/40 Balanced Allocation ETF quarterly revenues are --, which are smaller than VanEck Pharmaceutical ETF quarterly revenues of --. iShares Core 60/40 Balanced Allocation ETF's net income of -- is lower than VanEck Pharmaceutical ETF's net income of --. Notably, iShares Core 60/40 Balanced Allocation ETF's price-to-earnings ratio is -- while VanEck Pharmaceutical ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Core 60/40 Balanced Allocation ETF is -- versus -- for VanEck Pharmaceutical ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AORiShares Core 60/40 Balanced Allocation ETF-- -- -- -- PPHVanEck Pharmaceutical ETF-- -- -- --
-
Which has Higher Returns AOR or URTH?
iShares MSCI World ETF has a net margin of -- compared to iShares Core 60/40 Balanced Allocation ETF's net margin of --. iShares Core 60/40 Balanced Allocation ETF's return on equity of -- beat iShares MSCI World ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AORiShares Core 60/40 Balanced Allocation ETF-- -- -- URTHiShares MSCI World ETF-- -- -- -
What do Analysts Say About AOR or URTH?
iShares Core 60/40 Balanced Allocation ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares MSCI World ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Core 60/40 Balanced Allocation ETF has higher upside potential than iShares MSCI World ETF, analysts believe iShares Core 60/40 Balanced Allocation ETF is more attractive than iShares MSCI World ETF.
Company Buy Ratings Hold Ratings Sell Ratings AORiShares Core 60/40 Balanced Allocation ETF0 0 0 URTHiShares MSCI World ETF0 0 0 -
Is AOR or URTH More Risky?
iShares Core 60/40 Balanced Allocation ETF has a beta of 0.646, which suggesting that the stock is 35.369% less volatile than S&P 500. In comparison iShares MSCI World ETF has a beta of 0.922, suggesting its less volatile than the S&P 500 by 7.81%.
-
Which is a Better Dividend Stock AOR or URTH?
iShares Core 60/40 Balanced Allocation ETF has a quarterly dividend of $0.27 per share corresponding to a yield of 2.44%. iShares MSCI World ETF offers a yield of 1.27% to investors and pays a quarterly dividend of $1.26 per share. iShares Core 60/40 Balanced Allocation ETF pays -- of its earnings as a dividend. iShares MSCI World ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AOR or URTH?
iShares Core 60/40 Balanced Allocation ETF quarterly revenues are --, which are smaller than iShares MSCI World ETF quarterly revenues of --. iShares Core 60/40 Balanced Allocation ETF's net income of -- is lower than iShares MSCI World ETF's net income of --. Notably, iShares Core 60/40 Balanced Allocation ETF's price-to-earnings ratio is -- while iShares MSCI World ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Core 60/40 Balanced Allocation ETF is -- versus -- for iShares MSCI World ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AORiShares Core 60/40 Balanced Allocation ETF-- -- -- -- URTHiShares MSCI World ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Sell
44
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
